CD105 (Endoglin) as negative prognostic factor in AML

While several genetic and morphological markers are established and serve to guide therapy of acute myeloid leukaemia (AML), there is still profound need to identify additional markers to better stratify patients. CD105 (Endoglin) is a type I transmembrane protein reported to induce activation and p...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Sci Rep
Auteurs principaux: Kauer, Joseph, Schwartz, Karolin, Tandler, Claudia, Hinterleitner, Clemens, Roerden, Malte, Jung, Gundram, Salih, Helmut R., Heitmann, Jonas S., Märklin, Melanie
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group UK 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6892812/
https://ncbi.nlm.nih.gov/pubmed/31797971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-54767-x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires